Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
월요일, 9월 07

BeOne Medicines Ltd

ONCNASDAQ
Trade with Public
Trade with Public
$358.26
-4.42-1.22%
가까이에: Sep 4, 5:00 PM EST
$358.26
N/A
시간외: Sep 4, 4:00 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

BeOne Medicines Financials

BeOne Medicines (ONC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
BeOne Medicines Raises FY2026 Sales Guidance from $6.300B-$6.500B to $6.600B-$6.800B vs $6.479B Est

BeOne Medicines (NASDAQ:ONC) raises FY2026 sales outlook from $6.300 billion-$6.500 billion to $6.600 billion-$6.800 billion vs $6.479 billion estimate.
Benzinga Newsdesk

PRO
BeiGene Q2 Adj. EPS $3.84 Beats $1.44 Estimate, Sales $1.705B Beat $1.591B Estimate

BeiGene (NASDAQ:ONC) reported quarterly earnings of $3.84 per share which beat the analyst consensus estimate of $1.44 by 166.67 percent. This is a 70.67 percent increase over earnings of $2.25 per share from the same
Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
BeOne Medicines Raises FY2026 Sales Guidance from $6.200B-$6.400B to $6.300B-$6.500B vs $6.369B Est.

BeOne Medicines (NASDAQ:ONC) raises FY2026 sales outlook from $6.200 billion-$6.400 billion to $6.300 billion-$6.500 billion vs $6.369 billion estimate.
Benzinga Newsdesk

PRO
BeiGene Q1 Adj. EPS $3.24 Beats $0.79 Estimate, Sales $1.513B Beat $1.441B Estimate.

BeiGene (NASDAQ:ONC) reported quarterly earnings of $3.24 per share which beat the analyst consensus estimate of $0.79 by 310.13 percent. This is a 165.57 percent increase over earnings of $1.22 per share from the same
Benzinga Newsdesk

Earnings Scheduled For February 26, 2026

Benzinga Insights

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved